AAAAAA

   
Results: 1-8 |
Results: 8
Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells
Authors: Cuello, M Ettenberg, SA Nau, MM Lipkowitz, S
Citation: M. Cuello et al., Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells, GYNECOL ONC, 81(3), 2001, pp. 380-390
Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex
Authors: Ettenberg, SA Magnifico, A Cuello, M Nau, MM Rubinstein, YR Yarden, Y Weissman, AM Lipkowitz, S
Citation: Sa. Ettenberg et al., Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex, J BIOL CHEM, 276(29), 2001, pp. 27677-27684
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhancestumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosisin breast and ovarian cancer cell lines that overexpress erbB-2
Authors: Cuello, M Ettenberg, SA Clark, AS Keane, MM Posner, RH Nau, MM Dennis, PA Lipkowitz, S
Citation: M. Cuello et al., Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhancestumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosisin breast and ovarian cancer cell lines that overexpress erbB-2, CANCER RES, 61(12), 2001, pp. 4892-4900
Inhibition of NF-kappa B activity enhances TRAIL mediated apoptosis in breast cancer cell lines
Authors: Keane, MM Rubinstein, Y Cuello, M Ettenberg, SA Banerjee, P Nau, MM Lipkowitz, S
Citation: Mm. Keane et al., Inhibition of NF-kappa B activity enhances TRAIL mediated apoptosis in breast cancer cell lines, BREAST CANC, 64(2), 2000, pp. 211-219
Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1
Authors: Levkowitz, G Waterman, H Ettenberg, SA Katz, M Tsygankov, AY Alroy, I Lavi, S Iwai, K Reiss, Y Ciechanover, A Lipkowitz, S Yarden, Y
Citation: G. Levkowitz et al., Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1, MOL CELL, 4(6), 1999, pp. 1029-1040
cbl-3: a new mammalian cbl family protein
Authors: Keane, MM Ettenberg, SA Nau, MM Banerjee, P Cuello, M Penninger, J Lipkowitz, S
Citation: Mm. Keane et al., cbl-3: a new mammalian cbl family protein, ONCOGENE, 18(22), 1999, pp. 3365-3375
cbl-b inhibits epidermal growth factor receptor signaling
Authors: Ettenberg, SA Keane, MM Nau, MM Frankel, M Wang, LM Pierce, JH Lipkowitz, S
Citation: Sa. Ettenberg et al., cbl-b inhibits epidermal growth factor receptor signaling, ONCOGENE, 18(10), 1999, pp. 1855-1866
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
Authors: Keane, MM Ettenberg, SA Nau, MM Russell, EK Lipkowitz, S
Citation: Mm. Keane et al., Chemotherapy augments TRAIL-induced apoptosis in breast cell lines, CANCER RES, 59(3), 1999, pp. 734-741
Risultati: 1-8 |